ZOSTRIX HP
Natural health product licensed in Canada
- Licence holder
- Bausch & Lomb Inc.
- NPN or DIN-HM
- 02004240
- Status
- Active licence
- Licence date
- 2 April 2008
- Revision date
- 18 March 2025
- Form
- Crème
- Route of administration
- Topique
- Application type
- DIN de transition
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Eau purifiée, Myristate d'isopropyle, Monostéarate de glycéryle, Alcool cétylique, alcool benzylique, Sorbitol, Petrolatum, White
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | minimum: 1 Crème | minimum: 3 Tous les jours ; maximum: 4 Tous les jours |
Uses authorised in Canada
Used for the (temporary) relief of muscle and joint pain associated with rheumatoid arthritis or osteoarthritis, and pain of tendons and ligaments. Used to relieve skin (cutaneous) pain associated with conditions such as post-herpetic neuralgia and/or diabetic neuropathy.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Do not tightly bandage. Do not apply to wounds or damaged skin. Avoid thick applications. Wash hands thoroughly after use. Avoid contact with eyes and mucus membranes. If condition worsens or does not improve after 28 days, discontinue use and consult a physician. Call a poison Control Center immediately if overdose or accidental ingestion occurs. Do not apply with external heat, such as electric heating pad, as this may result in excessive skin irritation or skin burn. Keep out of reach of children. For external use only.
Source
Official Health Canada record, licence 02004240
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.